FDA unveils 25 initial 510(k) changes, refers controversial recommendations to the Institute of Medicine (IOM).

Sorry, there's nothing here.

Cite this paper

@article{Gilmore2011FDAU2, title={FDA unveils 25 initial 510(k) changes, refers controversial recommendations to the Institute of Medicine (IOM).}, author={Melissa Gilmore and Joseph J Hylak-Reinholtz}, journal={Health care law monthly}, year={2011}, volume={2011 6}, pages={2-7} }